Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466
CAS PubMed Article Google Scholar
Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
CAS PubMed Article Google Scholar
Singh SK, Clarke ID, Hide T et al (2004) Cancer stem cells in nervous system tumors. Oncogene 23:7267–7273
CAS PubMed Article Google Scholar
Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396–401
CAS PubMed Article Google Scholar
Andersen BM, Faust Akl C, Wheeler MA et al (2021) Glial and myeloid heterogeneity in the brain tumour microenvironment. Nat Rev Cancer 21:786–802
CAS PubMed Article Google Scholar
Hernandez A, Domenech M, Munoz-Marmol AM et al (2021) Glioblastoma: relationship between metabolism and immunosuppressive microenvironment. Cells 10(12):3529
CAS PubMed PubMed Central Article Google Scholar
Neftel C, Laffy J, Filbin MG et al (2019) An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 178(835–849):e821
Yang K, Wu Z, Zhang H et al (2022) Glioma targeted therapy: insight into future of molecular approaches. Mol Cancer 21:39
CAS PubMed PubMed Central Article Google Scholar
Hide T, Komohara Y, Miyasato Y et al (2018) Oligodendrocyte progenitor cells and macrophages/microglia produce glioma stem cell niches at the tumor border. EBioMedicine 30:94–104
PubMed PubMed Central Article Google Scholar
Hide T, Shibahara I, Kumabe T (2019) Novel concept of the border niche: glioblastoma cells use oligodendrocytes progenitor cells (GAOs) and microglia to acquire stem cell-like features. Brain Tumor Pathol 36:63–73
Ito N, Katoh K, Kushige H et al (2018) Ribosome incorporation into somatic cells promotes lineage transdifferentiation towards multipotency. Sci Rep 8:1634
PubMed PubMed Central Article CAS Google Scholar
Shirakawa Y, Hide T, Yamaoka M et al (2020) Ribosomal protein S6 promotes stem-like characters in glioma cells. Cancer Sci 111:2041–2051
CAS PubMed PubMed Central Article Google Scholar
Domenech M, Hernandez A, Plaja A et al (2021) Hypoxia: the cornerstone of glioblastoma. Int J Mol Sci 22(22):12608
CAS PubMed PubMed Central Article Google Scholar
Vartanian A, Singh SK, Agnihotri S et al (2014) GBM’s multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro Oncol 16:1167–1175
PubMed PubMed Central Article Google Scholar
Basheer AS, Abas F, Othman I et al (2021) Role of inflammatory mediators, macrophages, and neutrophils in glioma maintenance and progression: mechanistic understanding and potential therapeutic applications. Cancers (Basel) 13(16):4226
Simon T, Jackson E, Giamas G (2020) Breaking through the glioblastoma micro-environment via extracellular vesicles. Oncogene 39:4477–4490
CAS PubMed PubMed Central Article Google Scholar
Mohiuddin E, Wakimoto H (2021) Extracellular matrix in glioblastoma: opportunities for emerging therapeutic approaches. Am J Cancer Res 11:3742–3754
CAS PubMed PubMed Central Google Scholar
Broekman ML, Maas SLN, Abels ER et al (2018) Multidimensional communication in the microenvirons of glioblastoma. Nat Rev Neurol 14:482–495
PubMed PubMed Central Article Google Scholar
Kressler D, Hurt E, Bassler J (2010) Driving ribosome assembly. Biochim Biophys Acta 1803:673–683
CAS PubMed Article Google Scholar
Zhou X, Liao WJ, Liao JM et al (2015) Ribosomal proteins: functions beyond the ribosome. J Mol Cell Biol 7:92–104
CAS PubMed PubMed Central Article Google Scholar
Zhang D, Chen HP, Duan HF et al (2016) Aggregation of ribosomal protein S6 at nucleolus is cell cycle-controlled and its function in Pre-rRNA processing is phosphorylation dependent. J Cell Biochem 117:1649–1657
CAS PubMed Article Google Scholar
Biever A, Valjent E, Puighermanal E (2015) Ribosomal protein S6 phosphorylation in the nervous system: from regulation to function. Front Mol Neurosci 8:75
PubMed PubMed Central Article CAS Google Scholar
Chow S, Minden MD, Hedley DW (2006) Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients. Exp Hematol 34:1183–1191
CAS PubMed Article Google Scholar
Chen B, Tan Z, Gao J et al (2015) Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer. J Exp Clin Cancer Res 34:126
PubMed PubMed Central Article CAS Google Scholar
Khalaileh A, Dreazen A, Khatib A et al (2013) Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer. Cancer Res 73:1811–1820
CAS PubMed Article Google Scholar
Puchalski RB, Shah N, Miller J et al (2018) An anatomic transcriptional atlas of human glioblastoma. Science 360:660–663
CAS PubMed PubMed Central Article Google Scholar
Shirakawa Y, Ohta K, Miyake S et al (2021) Glioma cells acquire stem-like characters by extrinsic ribosome stimuli. Cells 10(11):2970
CAS PubMed PubMed Central Article Google Scholar
Court FA, Hendriks WT, MacGillavry HD et al (2008) Schwann cell to axon transfer of ribosomes: toward a novel understanding of the role of glia in the nervous system. J Neurosci 28:11024–11029
CAS PubMed PubMed Central Article Google Scholar
Lopez-Leal R, Alvarez J, Court FA (2016) Origin of axonal proteins: Is the axon-schwann cell unit a functional syncytium? Cytoskeleton (Hoboken) 73:629–639
Pinto G, Saenz-de-Santa-Maria I, Chastagner P et al (2021) Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids. Biochem J 478:21–39
CAS PubMed Article Google Scholar
Yi YW, You KS, Park JS et al (2021) Ribosomal protein S6: a potential therapeutic target against cancer? Int J Mol Sci 23(1):48
PubMed PubMed Central Article CAS Google Scholar
Pecoraro A, Pagano M, Russo G et al (2021) Ribosome biogenesis and cancer: overview on ribosomal proteins. Int J Mol Sci 22(11):5496
CAS PubMed PubMed Central Article Google Scholar
Orgebin E, Lamoureux F, Isidor B et al (2020) Ribosomopathies: new therapeutic perspectives. Cells 9(9):2080
CAS PubMed Central Article Google Scholar
Norris K, Hopes T, Aspden JL (2021) Ribosome heterogeneity and specialization in development. Wiley Interdiscip Rev RNA 12:e1644
CAS PubMed PubMed Central Article Google Scholar
Warner JR, McIntosh KB (2009) How common are extraribosomal functions of ribosomal proteins? Mol Cell 34:3–11
CAS PubMed PubMed Central Article Google Scholar
Narla A, Ebert BL (2010) Ribosomopathies: human disorders of ribosome dysfunction. Blood 115:3196–3205
CAS PubMed PubMed Central Article Google Scholar
Barna M, Pusic A, Zollo O et al (2008) Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 456:971–975
CAS PubMed PubMed Central Article Google Scholar
Bursac S, Prodan Y, Pullen N et al (2021) Dysregulated ribosome biogenesis reveals therapeutic liabilities in cancer. Trends Cancer 7:57–76
CAS PubMed Article Google Scholar
El Khoury W, Nasr Z (2021) Deregulation of ribosomal proteins in human cancers. Biosci Rep. https://doi.org/10.1042/BSR20211577
Article PubMed PubMed Central Google Scholar
Jeon YJ, Kim IK, Hong SH et al (2008) Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling. Oncogene 27:4344–4352
CAS PubMed Article Google Scholar
Yanai A, Inoue N, Yagi T et al (2015) Activation of mTOR/S6K but not MAPK pathways might be associated with high Ki-67, ER(+), and HER2(-) breast cancer. Clin Breast Cancer 15:197–203
留言 (0)